C. Chansin, T. Naciri, O. Villard, Y. Pers, A. Pontheaux, J. Jacques, V. Daien, S. Menjot De Chamfleur, L. Crampette, F. Mura, C. Aguilhon, É. Renard, I. Raingeard
{"title":"tocilizumab对Basedow病生物学参数的积极影响:对18例皮质耐药眼病患者的回顾性研究","authors":"C. Chansin, T. Naciri, O. Villard, Y. Pers, A. Pontheaux, J. Jacques, V. Daien, S. Menjot De Chamfleur, L. Crampette, F. Mura, C. Aguilhon, É. Renard, I. Raingeard","doi":"10.1016/j.ando.2020.07.228","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":7881,"journal":{"name":"Annales D Endocrinologie","volume":"77 1","pages":"225-226"},"PeriodicalIF":0.0000,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact positif du tocilizumab sur les paramètres biologiques de la maladie de Basedow : étude rétrospective chez 18 patients traités pour orbitopathie cortico-résistante\",\"authors\":\"C. Chansin, T. Naciri, O. Villard, Y. Pers, A. Pontheaux, J. Jacques, V. Daien, S. Menjot De Chamfleur, L. Crampette, F. Mura, C. Aguilhon, É. Renard, I. Raingeard\",\"doi\":\"10.1016/j.ando.2020.07.228\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":7881,\"journal\":{\"name\":\"Annales D Endocrinologie\",\"volume\":\"77 1\",\"pages\":\"225-226\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annales D Endocrinologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ando.2020.07.228\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales D Endocrinologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.ando.2020.07.228","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Impact positif du tocilizumab sur les paramètres biologiques de la maladie de Basedow : étude rétrospective chez 18 patients traités pour orbitopathie cortico-résistante